Topics | Cellgenetherapyreview.com

CGT top 10 storylines
Thursday, January 02, 2025
As we head into a new year, it’s time to look back at 2024 and appreciate the tremendous progress made in cell and gene therapy. read more
Switzerland: A rising hub for cell and gene therapies
Friday, December 13, 2024
With a well-established infrastructure that spans the entire pharma value chain from APIs to manufacturing, Switzerland is uniquely positioned to become a specialized hub for the most promising area of advanced medicine — cell and gene ... read more
FDA approvals for cell and gene therapies stay on track
Monday, November 25, 2024
The industry stays on track with FDA approvals for cell and gene therapies read more
Using rapid microbiological methods to ensure product safety
Friday, November 22, 2024
How flexible rapid testing can serve the different needs of cell and gene therapy manufacturers read more
Unlocking cell therapy’s potential
Friday, November 22, 2024
By continuing to crack the code of complex manufacturing, we can move closer to making long-lasting treatments affordable and available to all read more
Navigating the complexities of analytical validation for advanced therapies
Wednesday, November 20, 2024
Generating an analytical strategic plan and developing methods appropriately during process development will help ensure quality, safety and efficacy read more
Changing the model of care to advance CAR-T cell therapies
Wednesday, November 20, 2024
Autologous CAR-T cell therapies have already proven effective in treating hematological cancers, spurring extensive research into their potential for a wider range of diseases. read more
AAV characterization: current status and future advances
Wednesday, November 20, 2024
For the successful delivery of functional genes to patients, recombinant adenoviral-associated vectors (AAVs) are the most established and leading platform for rare and severe human diseases. read more
How preservation equipment can mitigate risk in CGT research
Wednesday, November 06, 2024
The limitations of current preservation approaches are driving researchers toward new alternatives read more
Maintaining contamination control in advanced therapy manufacturing
Wednesday, November 06, 2024
Facilities that make cell and gene therapies require cleaning and disinfection strategies not found at other drug manufacturing sites read more
Will the future include CAR-T-similars?
Thursday, October 31, 2024
Evaluating the factors that would support or preclude the birth and expansion of biosimilar versions of CAR-T therapies read more
Adding real-time analytics to automated cell therapy manufacturing
Wednesday, October 30, 2024
The synergy between automated cell expansion systems and real-time analyzers creates a powerful combination for monitoring cell expansion processes read more

Subscribe to Magazine

Get started here for your complimentary print or digital subscription

Jan/Feb/Mar 2026 edition now available!
Get started here for your complimentary print or digital subscription
Sign up Now »

INTERPHEX 2026
April 21-23, 2026
Meeting on the Med 2026
April 28-30, 2026
TRI-CON 2026: Entering the Age of AI
May 4-5, 2026